1. Companies
  2. ViaCyte

  3. Notes

ViaCyte

ViaCyte

Verified
First in Kind Cellular Treatment for Diabetes.
Launch date
Employees
51-200 people
Market cap
-
Net debt
-
Enterprise valuation
$320m (Public information from Jul 2022)
San Diego California (HQ)
http://viacyte.com
https://twitter.com/viacytehttps://www.facebook.com/viacytehttps://www.linkedin.com/company/viacyte-formerly-novocell-